Compare ALEMBIC LTD with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs BIOCON - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD BIOCON ALEMBIC LTD/
BIOCON
 
P/E (TTM) x 31.9 29.7 107.3% View Chart
P/BV x 2.7 3.8 71.7% View Chart
Dividend Yield % 0.4 0.3 144.6%  

Financials

 ALEMBIC LTD   BIOCON
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
BIOCON
Mar-19
ALEMBIC LTD/
BIOCON
5-Yr Chart
Click to enlarge
High Rs72707 10.2%   
Low Rs34554 6.1%   
Sales per share (Unadj.) Rs4.791.9 5.1%  
Earnings per share (Unadj.) Rs6.116.7 36.5%  
Cash flow per share (Unadj.) Rs6.224.2 25.8%  
Dividends per share (Unadj.) Rs0.201.00 20.0%  
Dividend yield (eoy) %0.40.2 238.2%  
Book value per share (Unadj.) Rs40.7101.6 40.0%  
Shares outstanding (eoy) m267.03600.00 44.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.36.9 164.2%   
Avg P/E ratio x8.737.7 23.0%  
P/CF ratio (eoy) x8.526.1 32.5%  
Price / Book Value ratio x1.36.2 21.0%  
Dividend payout %3.36.0 54.8%   
Avg Mkt Cap Rs m14,139378,330 3.7%   
No. of employees `000NA6.1 0.0%   
Total wages/salary Rs m20711,653 1.8%   
Avg. sales/employee Rs ThNM8,994.3-  
Avg. wages/employee Rs ThNM1,900.7-  
Avg. net profit/employee Rs ThNM1,635.3-  
INCOME DATA
Net Sales Rs m1,25555,144 2.3%  
Other income Rs m3701,444 25.6%   
Total revenues Rs m1,62556,588 2.9%   
Gross profit Rs m11115,883 0.7%  
Depreciation Rs m384,478 0.8%   
Interest Rs m2709 0.2%   
Profit before tax Rs m44212,140 3.6%   
Minority Interest Rs m09 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m242,123 1.1%   
Profit after tax Rs m1,63010,026 16.3%  
Gross profit margin %8.928.8 30.7%  
Effective tax rate %5.417.5 31.0%   
Net profit margin %129.818.2 714.2%  
BALANCE SHEET DATA
Current assets Rs m1,86748,228 3.9%   
Current liabilities Rs m59130,376 1.9%   
Net working cap to sales %101.632.4 314.0%  
Current ratio x3.21.6 198.9%  
Inventory Days Days9468 138.0%  
Debtors Days Days7486 86.0%  
Net fixed assets Rs m1,79164,130 2.8%   
Share capital Rs m5343,000 17.8%   
"Free" reserves Rs m10,32457,980 17.8%   
Net worth Rs m10,85860,980 17.8%   
Long term debt Rs m4115,766 0.3%   
Total assets Rs m11,591121,924 9.5%  
Interest coverage x260.918.1 1,439.5%   
Debt to equity ratio x00.3 1.5%  
Sales to assets ratio x0.10.5 23.9%   
Return on assets %14.18.8 159.9%  
Return on equity %15.016.4 91.3%  
Return on capital %15.216.8 90.7%  
Exports to sales %1.528.1 5.5%   
Imports to sales %21.018.9 111.3%   
Exports (fob) Rs m1915,506 0.1%   
Imports (cif) Rs m26310,399 2.5%   
Fx inflow Rs m1915,506 0.1%   
Fx outflow Rs m26410,399 2.5%   
Net fx Rs m-2445,107 -4.8%   
CASH FLOW
From Operations Rs m23611,546 2.0%  
From Investments Rs m-224-7,138 3.1%  
From Financial Activity Rs m-27-2,417 1.1%  
Net Cashflow Rs m-152,103 -0.7%  

Share Holding

Indian Promoters % 64.0 40.4 158.4%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.2 8.4 2.4%  
FIIs % 9.7 10.7 90.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 19.9 131.2%  
Shareholders   54,701 109,995 49.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  IPCA LABS  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Related Views on News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 5, 2020 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS